To assess the tendency of osteoclast differentiation in multiple myeloma, we prepared PBMCs from blood obtained from healthy individuals and patients with multiple myeloma and differentiated them into osteoclasts in the presence of M-CSF and RANKL stimulation. This evidence concerns the gene CSF1 and AL amyloidosis.